Skip to main content

Find Clinical Trials

Home
Conditions
Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer

Clinical trial condition

Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer

Explore clinical trials studying Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer trial results

Not Yet Recruiting

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

NCT06254066

Conditions: Female Breast Cancer Patients, HRD Positive Advanced Breast Cancer, Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer
Locations: Not specified

View Trial Details